October was always going to be a big month. My mother flew in from Scotland to start her six-week trip, so my duties as a ...

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, ...

If a widely held view turns out to be wrong or exaggerated, investors taking the other side of the bet can be rewarded.

Own an investment property or looking to get into the market? Find out how the impending interest rate cuts could affect you.

Shares in narrow-moat ResMed RMD remain undervalued following a solid first-quarter fiscal 2025. Underlying earnings before ...

A logical extension of trying to have the most money possible is to chase returns. An investor trying to have the most money ...

Nevertheless, we view shares in narrow-moat ARB are materially overvalued based on our unchanged forecasts and $27 fair value ...

How have so many wealthy families through history managed to squander their fortunes? This looks at the lessons from these ...

We maintain our $18.50 per share fair value estimate for narrow-moat Audinate AD8 following its first-quarter fiscal 2025 ...

Fiscal 2025 first-quarter results were largely in-line with our expectations but shares are trading at 25% premium to our ...

Alphabet GOOGL is set to release its third-quarter earnings report on Oct. 29. Here’s Morningstar’s take on what to look for ...

Here are three of my key investment takeaways from our conversation. “AI is serious,” admitted Grantham. “It will change ...